Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  vitamin E
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 35 for your search:
Start Over
Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1Z93, NCI-P94-0059
Phase III Randomized, Double-Blind, Placebo-Controlled Study of VIT-E for the Control of Hot Flushes in Menopausal Women with Prior Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-959253, NCI-P95-0065
Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068206, NCCTG-N99C5, NCI-P00-0169, NCT00006349
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000068277, S0000, U10CA037429, SWOG-S0000, CAN-NCIC-S0000, CALGB-S0000, ECOG-S0000, NCCAM, NCI-P00-0172, NCT00006392
Phase III Randomized, Placebo-Controlled Study of Beta-Carotene and Vitamin E in the Prevention of Lung Cancer (Summary Last Modified 10/88)
Phase: Phase III
Type: Prevention
Status: Closed
Age: 50 to 69
Sponsor:
Protocol IDs: DCPC-CPSB-10005
Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)
Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 69
Sponsor:
Protocol IDs: DCPC-CPSB-11204
Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271174, ECOG-1301, E1301, NCT00054561
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: CCCWFU-97202, U10CA081851, WFU 97202, NCT00096356
Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N05C3, NCI-2011-01712, CDR0000491071, N05C3, NCT00363129
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Closed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
Phase: Phase III
Type: Prevention
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: PRP1, CAN-NCIC-PRP1, CDR0000310096, NCT00064194
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: 69, R01HL043851, HL043851, CA047988, NCT00000479
S0000C Vitamin E and/or Selenium in Preventing Loss of Lung Function in Older Men Enrolled on SELECT Clinical Trial SWOG-S0000
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Completed
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617786, U10CA012027, S0000C, U10CA037429, SWOG-S0000C, NCT00782678
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Phase: Phase III
Type: Natural history/Epidemiology
Status: Closed
Age: 60 to 90
Sponsor: NCI, Other
Protocol IDs: IA0033, 5R01AG019241, SWOG-S0000A, S0000A, NCT00780689, NCT00040378
13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 92-0382, NCI-V94-0506, UCHSC-92382, NCT00002586
Phase II Study of Adjuvant Biologic Therapy for Preventing Recurrence and Second Primary Tumors in Patients with Stage III or IV Squamous Cell Cancer of the Head and Neck
Phase: Phase II
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-95015, NCI-H98-0011
Phase II Study of Isotretinoin (Accutane) plus rIFN-A in Adults with Mycosis Fungoides
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8816
Safety of Antioxidants During GYN Cancer Care
Phase: Phase II
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: 10006, NCT00284427
Trental & Vitamin E for Radiation-Induced Fibrosis
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: 200211003, NCT00583700
Phase I Randomized Study of Selenium With or Without Vitamin E for the Prevention of Lung Cancer in Smokers (Summary Last Modified 11/2000)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: KUMC-7159-97, NCI-P00-0152
Phase IB Toxicity Reduction Trial of TRA with VIT-E
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MCP-9199, NCI-T91-0173H, T91-0173
Start Over